关于细胞外囊泡参与不同癌症转移阶段的最新情况以及向策略
Keywan Mortezaee1, Jamal Majidpoor2
1Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Current medicinal chemistry
|January 22, 2024
概括
细胞外囊泡 (EVs) 对于癌症转移至关重要,调解细胞通信并帮助瘤扩散. 针对EV提供了一个有希望的治疗策略,以对抗这种致命的癌症方面.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 癌症转移仍然是癌症相关死亡的主要原因,在早期检测和向治疗方面存在重大挑战.
- 细胞外囊泡 (EVs) 越来越多地被认为是它们在细胞间通信中的作用,以及它们对瘤进展,预后和监测的影响.
- EVs是瘤细胞和瘤微环境之间的关键调解者,影响各种转移性步骤.
研究的目的:
- 审查目前对细胞外囊泡 (EVs) 如何促进癌症转移的理解.
- 提供有关EVs在转移级联的不同阶段参与的最新信息.
- 建议针对EV的潜在策略,以阻止癌症转移.
主要方法:
- 关于细胞外囊泡和癌症转移的当前研究的文献综述.
- 分析EVs在关键转移性过程中的作用,包括入侵和转移前利基形成.
- 探索电动汽车货物和膜组件作为潜在的生物标志物和治疗点.
主要成果:
- EVs是瘤细胞入侵,前转移性的形成和遥远器官的殖民的组成部分.
- 电动汽车的分子载荷和膜组成含有有价值的生物标志物,用于识别和监测瘤转移.
- 准EV是一种有希望的治疗途径,可以抑制癌症的进展和转移.
结论:
- 细胞外囊泡在通过细胞间通信促进癌症转移方面发挥着多方面的作用.
- 了解EV参与转移对于开发新型诊断和治疗策略至关重要.
- 向EV具有很大的潜力,可以开发新的抗癌疗法来对抗转移.
关键词:
细胞外囊泡 (EV) 是一种细胞外囊泡.癌症相关纤维细胞 (CAF)在外基因组中,外基因组是外基因组.转移 转移 转移 转移在前转移性利基 (PMN).转型增长因子 (TGF) 是一种转型增长因子.瘤微环境 (TME) 是指瘤的微环境.更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
5.8K
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
